Pinnacle Financial Partners Inc. Has $19.91 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)


Share on StockTwits

Pinnacle Financial Partners Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 137,064 shares of the company’s stock after buying an additional 791 shares during the quarter. HCA Healthcare makes up approximately 1.0% of Pinnacle Financial Partners Inc.’s investment portfolio, making the stock its 20th largest position. Pinnacle Financial Partners Inc.’s holdings in HCA Healthcare were worth $19,907,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in HCA. Sanders Capital LLC raised its holdings in HCA Healthcare by 3.8% in the 3rd quarter. Sanders Capital LLC now owns 7,133,533 shares of the company’s stock valued at $955,924,000 after acquiring an additional 259,582 shares during the period. FMR LLC boosted its holdings in shares of HCA Healthcare by 42.3% during the second quarter. FMR LLC now owns 2,148,926 shares of the company’s stock worth $208,575,000 after acquiring an additional 638,628 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its position in shares of HCA Healthcare by 1,884.5% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,805,900 shares of the company’s stock valued at $225,160,000 after purchasing an additional 1,714,900 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of HCA Healthcare by 28.1% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,728,319 shares of the company’s stock worth $215,487,000 after purchasing an additional 379,387 shares during the period. Finally, UBS Asset Management Americas Inc. lifted its holdings in HCA Healthcare by 14.7% during the 3rd quarter. UBS Asset Management Americas Inc. now owns 1,449,192 shares of the company’s stock worth $180,685,000 after purchasing an additional 185,477 shares during the last quarter. 58.98% of the stock is currently owned by hedge funds and other institutional investors.

In related news, SVP P. Martin Paslick sold 850 shares of the business’s stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $133.50, for a total value of $113,475.00. Following the sale, the senior vice president now directly owns 1,771 shares in the company, valued at approximately $236,428.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Bill B. Rutherford sold 36,250 shares of the company’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $139.33, for a total transaction of $5,050,712.50. Following the sale, the chief financial officer now directly owns 61,145 shares in the company, valued at $8,519,332.85. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 221,698 shares of company stock valued at $30,791,294. Insiders own 1.80% of the company’s stock.

Several research analysts have weighed in on HCA shares. The Goldman Sachs Group started coverage on HCA Healthcare in a research report on Tuesday, December 15th. They set a “buy” rating and a $191.00 price objective on the stock. JPMorgan Chase & Co. raised shares of HCA Healthcare from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $143.00 to $194.00 in a research report on Monday, December 14th. Zacks Investment Research downgraded shares of HCA Healthcare from a “hold” rating to a “sell” rating and set a $130.00 price objective for the company. in a report on Monday, November 2nd. CSFB increased their target price on shares of HCA Healthcare from $143.00 to $158.00 and gave the stock an “outperform” rating in a research report on Friday, October 9th. Finally, Raymond James lifted their price target on shares of HCA Healthcare from $140.00 to $150.00 and gave the company an “outperform” rating in a research report on Tuesday, October 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $160.35.

NYSE HCA traded down $1.77 during trading hours on Wednesday, reaching $170.47. The company’s stock had a trading volume of 860,454 shares, compared to its average volume of 1,463,557. The stock has a market cap of $57.68 billion, a P/E ratio of 17.42, a P/E/G ratio of 2.02 and a beta of 1.57. The firm has a fifty day simple moving average of $161.63 and a 200-day simple moving average of $136.10. The company has a debt-to-equity ratio of 23.70, a current ratio of 1.13 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 52 week low of $58.38 and a 52 week high of $174.55.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Monday, October 26th. The company reported $1.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.69 by ($0.77). HCA Healthcare had a return on equity of 2,032.72% and a net margin of 6.70%. The business had revenue of $13.31 billion for the quarter, compared to analyst estimates of $12.92 billion. During the same quarter in the previous year, the business posted $2.23 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. On average, research analysts expect that HCA Healthcare, Inc. will post 7.01 earnings per share for the current year.

The company also recently disclosed a — dividend, which will be paid on Wednesday, January 13th. Shareholders of record on Thursday, December 31st will be given a $0.2678 dividend. The ex-dividend date is Wednesday, December 30th.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What is a Derivative?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.